Deaths from lung cancer could be reduced by better policies to control indoor radon

January 7, 2009,

About 1100 people each year die in the UK from lung cancer related to indoor radon, but current government protection policies focus mainly on the small number of homes with high radon levels and neglect the 95% of radon related deaths caused by lower levels of radon, according to a study published on bmj.com today.

The authors argue that installing basic and cheap measures to prevent radon in all new homes would be more cost-effective and have greater potential for reducing lung cancer deaths caused by radon, and UK Building Regulations should be amended to enforce this.

Radon in the home is a natural air pollutant produced by the decay of uranium in the ground. Radon gas seeps into buildings through cracks and holes in the foundations and when it decays it produces particles that can enter the lungs and expose them to damaging radiation.

At present, government policies in the UK concentrate on searching for homes with high levels of radon and encouraging homeowners to take remedial action at their own expense.

Professor Alastair Gray, Professor Sarah Darby and other colleagues from the University of Oxford, assessed the contribution of indoor radon to lung cancer deaths in the UK, and examined the cost- effectiveness of policies to control radon exposure. They used recent evidence on the risk of lung cancer from indoor radon, based on data from 7,000 people with lung cancer and more than 21,000 people without lung cancer across Europe. They then calculated the lifetime risk of lung cancer death before and after various interventions to control radon, and the costs involved.

The authors estimate that 1100 deaths a year in the UK are related to radon, about 3.3% of all deaths from lung cancer, but less than 5% of radon related deaths occur from exposure above the current action level. In addition, they report that many homeowners refuse to have their home tested or to spend money reducing radon levels. As a result these policies are costly and have a minimal impact on radon related deaths.

In contrast, the authors found that installing simple preventive measures in new homes is highly cost-effective, but at present is only being done in selected areas of the country. This should be rolled out across the whole UK, say the authors, and should be backed up by changes to the Building Regulations. A gas-resistant membrane in the foundations would reduce radon by about 50% and would cost only about £100.

Importantly, the study also found that six out of seven radon related lung cancers occur in people who smoke or who have smoked in the past. The best way for current smokers to reduce risk is to stop smoking. Current and former smokers can also reduce their risk by taking radon control measures seriously, say the authors.

The authors suggest that their findings are relevant to many other countries, most of which have higher concentrations of radon than the UK. The average radon concentration in UK homes is 21 bequerels per cubic metre, but in the European Union the average is 55, suggesting that about 8% of deaths from lung cancer, or 18,000 deaths each year, are caused by radon across the EU.

This is the most extensive and detailed evaluation to date of the policies to counter radon-induced and deaths from lung cancer, say Professor Anssi Auvinen from the University of Tampere in Finland and Professor Göran Pershagen from the Institute of Environmental Medicine in Sweden, in an accompanying editorial.

The findings suggest that:"Radon policies need to be scrutinised [and particularly in populations with low average levels], the priority should be to apply basic measures universally rather than to take action only when high radon levels have been identified by measurement."

Source: British Medical Journal

Explore further: A cough that won't quit—is it lung cancer?

Related Stories

A cough that won't quit—is it lung cancer?

December 15, 2017
Coughing removes particles, mucus, irritants or fluids from the lungs. It may be caused by something in the air, such as cooking fumes, perfume or spices, or it may be related to congestion caused by a cold, allergies or ...

Best ways to quit smoking, cut your lung cancer risk

January 6, 2018
(HealthDay)—While there is no sure way to avoid lung cancer, there are steps you can take to reduce your risk.

Study examines increase in lung cancer risk from combined radon and tobacco smoke exposure

April 25, 2014
In the words of Dr. Ellen Hahn, professor in the University of Kentucky's colleges of nursing and public health, Kentucky has the "triple crown of lung cancer" - the country's highest rate of smoking combined with high rates ...

Lung cancer not on many women's radar, survey finds

May 13, 2014
(HealthDay)—U.S. women still see breast cancer as a bigger killer than lung cancer, despite the fact that lung cancer kills more Americans each year—women and men—than any other cancer.

Low radon concentrations accurately measurable for the first time

July 24, 2013
You can't see it, you can't smell it, you can't taste it – but at high doses, it can be lethal: the natural radioactive noble gas radon occurs especially in places where the subsoil consists of granite. It can, however, ...

Pinpointing a specific cause of lung cancer isn't possible

May 12, 2016
Dear Mayo Clinic: My brother-in-law has never smoked, but was diagnosed with late-stage lung cancer at the age of 45. He was told there is no way to determine what caused it, even though he had a biopsy. What are some of ...

Recommended for you

Researchers discover novel mechanism linking changes in mitochondria to cancer cell death

February 20, 2018
To stop the spread of cancer, cancer cells must die. Unfortunately, many types of cancer cells seem to use innate mechanisms that block cancer cell death, therefore allowing the cancer to metastasize. While seeking to further ...

Stem cell vaccine immunizes lab mice against multiple cancers

February 15, 2018
Stanford University researchers report that injecting mice with inactivated induced pluripotent stem cells (iPSCs) launched a strong immune response against breast, lung, and skin cancers. The vaccine also prevented relapses ...

Induced pluripotent stem cells could serve as cancer vaccine, researchers say

February 15, 2018
Induced pluripotent stem cells, or iPS cells, are a keystone of regenerative medicine. Outside the body, they can be coaxed to become many different types of cells and tissues that can help repair damage due to trauma or ...

Team paves the way to the use of immunotherapy to treat aggressive colon tumors

February 15, 2018
In a short space of time, immunotherapy against cancer cells has become a powerful approach to treat cancers such as melanoma and lung cancer. However, to date, most colon tumours appeared to be unresponsive to this kind ...

Can our genes help predict how women respond to ovarian cancer treatment?

February 15, 2018
Research has identified gene variants that play a significant role in how women with ovarian cancer process chemotherapy.

First comparison of common breast cancer tests finds varied accuracy of predictions

February 15, 2018
Commercially-available prognostic breast cancer tests show significant variation in their abilities to predict disease recurrence, according to a study led by Queen Mary University of London of nearly 800 postmenopausal women.

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

Soylent
1 / 5 (1) Jan 07, 2009
The LNT model is still just a hypothesis in the low dose region.

We ought to find out if it's true or not; but unfortunately it's experimentally very difficult due to the very low rate of cancers from radiation as opposed to regular metabolism and other causes.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.